According to a new Netscribes report published on Research on Global Markets, the global multiplex biomarker imaging market is expected to have a compound annual growth rate (CAGR) of 12% till 2023, and reach a market size of USD 523.59 Mn during the 2018 – 2023 period.

According to the new report, the demand for multiplex biomarker imaging is on the rise across the world owing to its unique ability to detect the presence of, severity, and exact location of chronic diseases and tumors. The report also features a comprehensive analysis of all the market segments by techniques, components, applications, and end users. Among techniques, immunohistochemistry (IHC) currently holds the largest market share due to its extensive use in research laboratories as well as for clinical diagnostics. In terms of applications, currently, multiplex biomarker imaging products are used in oncology studies mostly.

Region wise, North America dominates the global multiplex biomarker imaging market in terms of market share. However, despite North America being the market leader, the Asia Pacific region is expected to witness the highest CAGR expansion during the forecasted period, according to Netscribes.

Check out the Research on Global Markets report featured in this article:

Global Multiplex Biomarker Imaging Market (2018-2023)
November 2018 | 90-100 Pages | SKU: 201823

Key highlights of this report:

  • Global market overview - historical (2015–2017) and forecasted (2018–2023) market size (USD Bn), geography-wise market revenue (USD Bn), and market attractiveness analysis
  • Qualitative analysis of the drivers and challenges affecting the global market
  • Major trends in the global multiplex biomarker imaging market
  • Analysis of the competitive landscape and profiles of the major players operating in the market
  • Market segmentation based on technique (immunohistochemistry [IHC], fluorescent in situ hybridization [FISH], immunofluorescence [IF], tissue microarray [TMA], toponome imaging system [TIS]) – historical (2015–2017) and forecasted (2018–2023) market size (USD Mn), and key market observations
  • Market segmentation based on component (instrument, reagents and kits, software) – historical (2015–2017) and forecasted (2018–2023) market size (USD Mn), and key observations
  • Market segmentation based on application (oncology studies, drug safety, genetic characterization and others [neurodegeneration, protein research]) – historical (2015–2017) and forecasted (2018–2023) market size (USD Mn), and key observations
  • Market segmentation based on end user (research institutes, translational labs, pharma and biopharma companies) – historical (2015–2017) and forecasted (2018–2023) market size (USD Mn), and key observations
  • Market segmentation based on region (North America, Europe, Asia-Pacific, Latin America, and The Middle East and Africa)

This report has been formulated and designed with the purpose of giving businesses a concise understanding of the demand for multiplex biomarker imaging products worldwide to determine the viability of the market, develop strategies based on the drivers, and to help brands identify competition and respond accordingly.

Name: Ankita Basu
Email: ankita.basu@netscribes.com
US Toll-Free: 18888313350
M: +91 9903154956